PortalPublikationenEfficacy of metacognitive training for patients with borderl...

Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results

Standard

Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results. / Schilling, Lisa; Moritz, Steffen; Kriston, Levente; Krieger, Maria; Nagel, Matthias.

in: PSYCHIAT RES, Jahrgang 262, 04.2018, S. 459-464.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schilling, L, Moritz, S, Kriston, L, Krieger, M & Nagel, M 2018, 'Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results', PSYCHIAT RES, Jg. 262, S. 459-464. https://doi.org/10.1016/j.psychres.2017.09.024

APA

Schilling, L., Moritz, S., Kriston, L., Krieger, M., & Nagel, M. (2018). Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results. PSYCHIAT RES, 262, 459-464. https://doi.org/10.1016/j.psychres.2017.09.024

Vancouver

Schilling L, Moritz S, Kriston L, Krieger M, Nagel M. Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results. PSYCHIAT RES. 2018 Apr;262:459-464. https://doi.org/10.1016/j.psychres.2017.09.024

Bibtex

@article{3543a0ece1e84685a4c6fe4f911eb669,
title = "Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results",
abstract = "'Metacognitive training for borderline personality disorder' (B-MCT) represents a complementary group intervention. It aims at raising awareness for cognitive biases that may play an important role in the development and maintenance of borderline symptomatology. For the present study, we evaluated the effectiveness of this new approach against a control condition. Seventy-four inpatients with borderline personality disorder (BPD) were randomly assigned to metacognitive training for BPD or progressive muscle relaxation training as an add-on intervention to treatment as usual. Severity of symptomatology was assessed at baseline, four weeks after beginning and six months after completion of the intervention. The per-protocol and intention-to-treat analyses revealed that patients in the metacognitive training group showed significantly greater reductions on the primary outcome (Borderline Symptom List-23) after six months. Progressive muscle relaxation was superior in alleviating depressive symptoms (secondary outcome: Beck Depression Inventory) at the long-term follow-up. Findings provide preliminary evidence that metacognitive training for BPD yields surplus effects to standard treatment.",
keywords = "Journal Article, Research Support, Non-U.S. Gov't",
author = "Lisa Schilling and Steffen Moritz and Levente Kriston and Maria Krieger and Matthias Nagel",
note = "Copyright {\textcopyright} 2017 Elsevier B.V. All rights reserved.",
year = "2018",
month = apr,
doi = "10.1016/j.psychres.2017.09.024",
language = "English",
volume = "262",
pages = "459--464",
journal = "PSYCHIAT RES",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - Efficacy of metacognitive training for patients with borderline personality disorder: Preliminary results

AU - Schilling, Lisa

AU - Moritz, Steffen

AU - Kriston, Levente

AU - Krieger, Maria

AU - Nagel, Matthias

N1 - Copyright © 2017 Elsevier B.V. All rights reserved.

PY - 2018/4

Y1 - 2018/4

N2 - 'Metacognitive training for borderline personality disorder' (B-MCT) represents a complementary group intervention. It aims at raising awareness for cognitive biases that may play an important role in the development and maintenance of borderline symptomatology. For the present study, we evaluated the effectiveness of this new approach against a control condition. Seventy-four inpatients with borderline personality disorder (BPD) were randomly assigned to metacognitive training for BPD or progressive muscle relaxation training as an add-on intervention to treatment as usual. Severity of symptomatology was assessed at baseline, four weeks after beginning and six months after completion of the intervention. The per-protocol and intention-to-treat analyses revealed that patients in the metacognitive training group showed significantly greater reductions on the primary outcome (Borderline Symptom List-23) after six months. Progressive muscle relaxation was superior in alleviating depressive symptoms (secondary outcome: Beck Depression Inventory) at the long-term follow-up. Findings provide preliminary evidence that metacognitive training for BPD yields surplus effects to standard treatment.

AB - 'Metacognitive training for borderline personality disorder' (B-MCT) represents a complementary group intervention. It aims at raising awareness for cognitive biases that may play an important role in the development and maintenance of borderline symptomatology. For the present study, we evaluated the effectiveness of this new approach against a control condition. Seventy-four inpatients with borderline personality disorder (BPD) were randomly assigned to metacognitive training for BPD or progressive muscle relaxation training as an add-on intervention to treatment as usual. Severity of symptomatology was assessed at baseline, four weeks after beginning and six months after completion of the intervention. The per-protocol and intention-to-treat analyses revealed that patients in the metacognitive training group showed significantly greater reductions on the primary outcome (Borderline Symptom List-23) after six months. Progressive muscle relaxation was superior in alleviating depressive symptoms (secondary outcome: Beck Depression Inventory) at the long-term follow-up. Findings provide preliminary evidence that metacognitive training for BPD yields surplus effects to standard treatment.

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1016/j.psychres.2017.09.024

DO - 10.1016/j.psychres.2017.09.024

M3 - SCORING: Journal article

C2 - 28927866

VL - 262

SP - 459

EP - 464

JO - PSYCHIAT RES

JF - PSYCHIAT RES

SN - 0165-1781

ER -